Tag Archives: Alliance for Regenerative Medicine

Alliance for Regenerative Medicine (ARM) Neuralstem Presentation

Alliance for Regenerative Medicine (ARM) Neuralstem Presentation April 17, 2018 Neuralstem is a clinical-stage biopharmaceutical company developing novel treatments for nervous system diseases of high unmet medical need. The company’s lead asset and stem cell therapy candidate, NSI-566, is a … Continue reading

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research, Stem Cell Research | Tagged ,

InVivo Therapeutics at Meeting on the Mesa

InVivo Therapeutics Video Presentation at Alliance for Regenerative Medicine 6th Annual Partnering Forum Tom Ulich, M.D., Chief Scientific Officer, Cambridge, MA (NASDAQ: NVIV)

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research | Tagged , ,

Alliance for Regenerative Medicine: Stem Cells 2014

Presented by: Teresa Leezer, CEO RhinoCyte, Inc. is a privately owned biopharmaceutical company focused on developing transformational technologies that will change the way neurodegenerative disorders are treated. Founded in 2005, the Company is advancing innovative treatment paradigms that leverage proprietary … Continue reading

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research, Stem Cell Research | Tagged , , , ,

Stem Cells Inc. update at Alliance for Regenerative Medicine (ARM)

Martin McGlynn, President and CEO of Stem Cells Inc. gives an update on Investor Day in New York City. For spinal cord injury they plan to release data in the second quarter of 2014 and open 20-30 additional sites to … Continue reading

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Stem Cell Research | Tagged , ,

CNS Panel Discussion, StemCells Inc. and Asterias Biotherapeutics at Alliance for Regenerative Medicine Investor Day

The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field … Continue reading

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, Spinal Research, Stem Cell Research | Tagged , , , , , , , , , , , , , , , , , , ,

Time for Some Bold Steps: Why We Need a National Strategy and Initiative in Regenerative Medicine and What It Could Include

Dr. Gil Van Bokkelen Chairman, Alliance for Regenerative Medicine There is intense public interest in the medical potential of regenerative medicine, and in my opinion for very good reason. Those of us that are actively engaged in and/or closely follow … Continue reading

Posted in Advocacy, Regenerative Medicine | Tagged , , , , , , , , | 2 Comments